Your browser version may not work well with NCBI's Web applications. More information here...
1: Cancer Res. 1989 Oct 1;49(19):5323-8.Click here to read Links
Comment in:
Cancer Res. 1990 Mar 1;50(5):1667.

Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells.

Dear TN, McDonald DA, Kefford RF.

Department of Medicine, University of Sydney, Westmead Hospital, N.S.W., Australia.

We have investigated differences in gene expression between a metastatic and nonmetastatic clone of the DMBA-8 rat mammary adenocarcinoma cell line and have previously identified a differentially expressed gene WDNM1 (T.N. Dear, I.A. Ramshaw, and R.F. Kefford, Cancer Res., 48: 5203-5209, 1988). To further investigate differences in mRNA expression between these cell lines, a complementary DNA library from the nonmetastatic cell line was probed with labeled complementary DNA enriched for sequences specific to this line. We report here the identification in nonmetastatic cells of a second gene, WDNM2, which encodes a 1.7-kilobase mRNA corresponding to a protein (Mr 28,000-30,000) the expression of which shows a positive correlation with the nonmetastatic phenotype in three independently derived rat mammary adenocarcinoma cell lines and is regulated transcriptionally. Homologous sequences in the human genome have been identified. The function of this new gene may relate to regulation of the metastatic phenotype in this tumor.

PMID: 2504488 [PubMed - indexed for MEDLINE]